Table 1.
Characterization of the Six Pathogenic APC Variants
| FAP no. | APC mutation | Exon/intron | Predicted effect | Influence on normal splice efficiency (BDGP) | RNA processing | Phenotype |
|---|---|---|---|---|---|---|
| 1159* | c.531 + 5G>C | Intron 4 | 0.98 to 0.25 | Deletion of exon 4, premature stop codon | Attenuated | |
| 1398 | c.532 − 8G>A | Intron 4 | 0.45 to <0.01 new SA site: 0.98 | Aberrant transcript, premature stop codon | Classic | |
| 1476 | c.1409-2_1409 delAGG | Intron 10 | Destruction of SA site | Activation of two cryptic SA sites | Two aberrant transcripts, premature stop codon | Attenuated |
| 0005 | c.1548G>A | Exon 11 | p.Lys516 | 1.00 to 0.84 | Deletion of exon 11, premature stop codon | Classic |
| 1172 | c.1742A>G | Exon 13 | p.Lys581Arg | 0.92 to 0.78 | Deletion of exon 13 | Attenuated |
| 1199 | dup exon 10 to 11 | Exon 10 to 11 | Duplication of exon 10 to 11, premature stop codon | Classic |
SA, splice acceptor site; BDGP, Berkeley Drosophila Genome Project (splice prediction program).
Also reported by Moisio et al.36